Product Description
Product Name: Blaztere 4 mg Injection
Active Ingredient: Zoledronic Acid
Strength: 4 mg
Form: Solution for Intravenous Infusion
Category: Bisphosphonate / Bone Resorption Inhibitor
Indications: Osteoporosis, Hypercalcemia of Malignancy, Paget’s Disease, Bone Metastases
Blaztere 4 mg Injection contains Zoledronic Acid, a bisphosphonate medication used to treat and prevent bone-related complications in a range of conditions. It is primarily indicated for the treatment of osteoporosis in postmenopausal women, and is also effective in men and women undergoing long-term corticosteroid therapy.
